For more information

on this study please

call +1 877-379-3718

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.

Study ID

112795

Study Title A two part, multicenter Phase IIa, placebo controlled study, to examine the safety, tolerability, and effects of GSK256073 on lipids in subjects with dyslipidemia
Clinicaltrials.gov Identifier NCT00903617
Sponsor GlaxoSmithKline
Collaborators N/A
Study Recruitment Status Completed
Generic Name GSK256073
Trade Name GSK256073
Study Indication Dyslipidaemias